CSF2 and neoplasm: It is also important to note that randomization of patients to treatment was not stratified by tumor location and that, although randomization in the overall population was 2:1 (talimogene laherparepvec:GM‐CSF), fewer patients with cutaneous head and neck melanoma were randomized to the GM‐CSF arm; the ratio in this analysis was 2.35:1.